Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.65
-0.45 (-1.13%)
Apr 20, 2026, 1:22 PM CST
Market Cap1.67B -3.4%
Revenue (ttm)220.40M +128.2%
Net Income58.93M
EPS1.40
Shares Out42.00M
PE Ratio28.32
Forward PEn/a
Dividend1.00 (2.52%)
Ex-Dividend DateApr 9, 2026
Volume41,274
Average Volume173,137
Open39.65
Previous Close39.65
Day's Range39.05 - 40.40
52-Week Range35.45 - 80.40
Beta0.58
RSI39.33
Earnings DateMay 5, 2026

About Taiwan Biomaterial

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan. [Read more]

Sector Healthcare
Founded 1921
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6649
Full Company Profile

Financial Performance

Financial Statements